“…GAL treatment of rat microglia significantly increases the phagocytosis of amyloid β (Aβ) peptide and facilitates the clearance of Aβ in the brain of rodents with AD [ 22 ]. This multitarget action of GAL makes it a valuable drug for AD treatment and stimulates the search for new GAL derivatives with higher affinity to AChE [ 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ].…”